Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verastem (VSTM) Invested Capital: 2018-2025

Historic Invested Capital for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to -$15.5 million.

  • Verastem's Invested Capital fell 174.18% to -$15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.5 million, marking a year-over-year decrease of 174.18%. This contributed to the annual value of -$28.9 million for FY2024, which is N/A change from last year.
  • Per Verastem's latest filing, its Invested Capital stood at -$15.5 million for Q3 2025, which was down 143.06% from $36.1 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Invested Capital ranged from a high of $102.6 million in Q1 2021 and a low of -$32.4 million during Q1 2025.
  • Moreover, its 3-year median value for Invested Capital was $24.4 million (2024), whereas its average is $24.7 million.
  • Per our database at Business Quant, Verastem's Invested Capital surged by 88.51% in 2023 and then tumbled by 229.41% in 2025.
  • Quarterly analysis of 5 years shows Verastem's Invested Capital stood at $87.6 million in 2021, then slumped by 45.88% to $47.4 million in 2022, then spiked by 32.30% to $83.2 million in 2023, then slumped by 74.84% to -$28.9 million in 2024, then slumped by 174.18% to -$15.5 million in 2025.
  • Its Invested Capital stands at -$15.5 million for Q3 2025, versus $36.1 million for Q2 2025 and -$32.4 million for Q1 2025.